CLINICAL NEUROMYTHOLOGY .9. PYRAMID SALE IN THE BUCKET SHOP - DATATOP BOTTOMS OUT

被引：55

作者：

LANDAU, WM

机构：

来源：

NEUROLOGY | 1990年 / 40卷 / 09期

关键词：

D O I：

10.1212/WNL.40.9.1337

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1337 / 1339

页数：3

共 8 条

[1]

ELIZAN TS, 1990, ARCH NEUROL-CHICAGO, V47, P160

[2] SELEGILINE AS AN ADJUNCT TO CONVENTIONAL LEVODOPA THERAPY IN PARKINSONS-DISEASE - EXPERIENCE WITH THIS TYPE-B MONOAMINE-OXIDASE INHIBITOR IN 200 PATIENTS [J].

ELIZAN, TS ;

YAHR, MD ;

MOROS, DA ;

MENDOZA, MR ;

PANG, S ;

BODIAN, CA .

ARCHIVES OF NEUROLOGY, 1989, 46 (12) :1280-1283

[3] SELEGILINE USE TO PREVENT PROGRESSION OF PARKINSONS-DISEASE - EXPERIENCE IN 22 DENOVO PATIENTS [J].

ELIZAN, TS ;

YAHR, MD ;

MOROS, DA ;

MENDOZA, MR ;

PANG, S ;

BODIAN, CA .

ARCHIVES OF NEUROLOGY, 1989, 46 (12) :1275-1279

[4] LONG-TERM FOLLOW-UP OF EARLY DOPA TREATMENT IN PARKINSONS-DISEASE [J].

MARKHAM, CH ;

DIAMOND, SG .

ANNALS OF NEUROLOGY, 1986, 19 (04) :365-372

[5] EVIDENCE TO SUPPORT EARLY LEVODOPA THERAPY IN PARKINSON DISEASE [J].

MARKHAM, CH ;

DIAMOND, SG .

NEUROLOGY, 1981, 31 (02) :125-131

[6] THE EFFECT OF DEPRENYL (SELEGILINE) ON THE NATURAL-HISTORY OF PARKINSONS-DISEASE [J].

TETRUD, JW ;

LANGSTON, JW .

SCIENCE, 1989, 245 (4917) :519-522

[7]

1989, NEW ENGL J MED, V321, P1364

[8]

1989, ARCH NEUROL-CHICAGO, V46, P1052

← 1 →